Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to: âCorrespondence on: âInterleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammationâan open-label cohort studyâ by Della-Torre et al â by Cheng and Zhang
Della-Torre, Emanuel, Landoni, Giovanni, Zangrillo, Alberto, Dagna, LorenzoJournal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2020-218724
Date:
August, 2020
File:
PDF, 209 KB
2020